AU Patent

AU2021227204A1 — Intraocular drug delivery platform

Assigned to University of Colorado Colorado Springs · Expires 2022-09-15 · 4y expired

What this patent protects

An intraocular drug delivery platform for use with an intraocular lens assembly. The platform includes a ring and haptics to maintain the ring in position in the capsular bag, compartments on the anterior surface of the ring for accommodating a drug eluting matrix or other drug m…

USPTO Abstract

An intraocular drug delivery platform for use with an intraocular lens assembly. The platform includes a ring and haptics to maintain the ring in position in the capsular bag, compartments on the anterior surface of the ring for accommodating a drug eluting matrix or other drug mass, and a skirt extending posteriorly from the posterior surface of the ring to constrain movement, including lateral or inferior/superior movement, of the intraocular lens relative to the ring.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021227204A1
Jurisdiction
AU
Classification
—
Expires
2022-09-15
Drug substance claim
No
Drug product claim
No
Assignee
University of Colorado Colorado Springs
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.